Josh Enomoto

Josh Enomoto

Brokering multi-million-dollar deals with some of the world’s biggest companies and providing in-depth marketing analyses, Josh Enomoto takes his firsthand knowledge of the corporate boardroom and delivers them across several media outlets. In addition to his work at InvestorPlace, Josh contributes content for Benzinga, TipRanks, EmergingGrowth and Blockster. He is also a guest expert at CGTN America.

While leaving no stone unturned regarding sector coverage, Josh has written extensively about cryptocurrencies. You can follow him on Blockster, a crypto-centric social media platform and on LinkedIn.

Recent Articles

Is the Price Finally Right for Much-Loved Zomedica Stock?

Thanks to its cost-saving pet diagnostics platform, many investors are turning positive on Zomedica. Is now the time to strike with ZOM stock?

CRISPR Therapeutics Is a Falling Knife You Don’t Want to Catch

With possibly the worst of the novel coronavirus pandemic over, on the surface CRSP stock seems to be a worthwhile rebound pick. However, the technical outlook suggests otherwise.

7 Stocks That Cathie Wood Likes and You Should Too

The anti-Wolf of Wall Street, Cathie Wood brings honesty and integrity to the world of high finance. Her strong track record confirms that nice folks can finish first.

Learn a Lesson From GameStop Before Buying Tanger Factory Outlet Centers

As GameStop demonstrated, betting on a short squeeze can be profitable. However, the tactic may be overdone, which is why SKT stock presents too much of a dangerous case.

The Graph Compels but Risks Getting Overwhelmed by Crypto Fever

With so much fanfare over Bitcoin, GRT-USD stock seems like a great alternative, in part due to its underlying innovations. However, you need to consider how wild this space is before taking a shot.